URGN
UroGen Pharma Ltd. Ordinary Shares
$45.88
-1.04%
-0.48
Notify me if price changes either direction
Buy URGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
2.3B
Enterprise value
2.4B
Trailing PE
-14.382445141066
Forward PE
16.590977
PEG Ratio
0.19612425192362
Enterprise to EBITDA
-35.485
Enterprise to revenue
12.474
Price to book MRQ
-17.458530005136
Price to sales TTM
12.006862
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
188.7M
EBITDA
-66345000
Diluted EPS TTM
-1.98
Total Cash (MRQ)
108.0M
Current ratio (MRQ)
3.802
Operating Cash Flow (TTM)
-158916992
URGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
